Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.63 |
| ▸ | TTR | P02766 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | DHFR | P00374 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ALB | P02768 | 1/20 | 0.53 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.53 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9672293 | 0.88 | KEAP1 (0.52) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL6498591 | 0.87 | HSD17B10 (0.58) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL31586500 | 0.87 | HSD17B10 (0.58) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL20601776 | 0.87 | ACMSD (0.53) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL31585927 | 0.87 | ACMSD (0.53) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL17796951 | 0.86 | FOLH1 (0.57) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL31585949 | 0.86 | FOLH1 (0.57) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL28432657 | 0.84 | KDM4E (0.49) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL30827040 | 0.84 | KEAP1 (0.47) | KEAP1TTRHSD17B10KDM4EHIF1A | |
| SCHEMBL336978 | 0.83 | KEAP1 (0.65) | KEAP1TTRHSD17B10KDM4EHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119264851-A | Type-C male connector epoxy pouring sealant and preparation method thereof | 青岛德聚胶接技术有限公司 | 2025-01-07 | — | — | CN | disclosed |
| US-12077611-B2 | Cyclic peptides multimers targeting α4β7 integrin | ZEALAND PHARMA A/S (DK) | 2024-09-03 | — | — | US | disclosed |
| CN-114315678-B | Aryl diperoxoic acid and preparation method and application thereof | 哈尔滨工业大学（深圳） | 2024-04-12 | — | — | CN | disclosed |
| US-20230406884-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ZEALAND PHARMA A/S (DK) | 2023-12-21 | — | — | US | disclosed |
| US-11713338-B2 | Cyclic peptides multimers targeting α-4-β-7 integrin | ZEALAND PHARMA A/S (DK) | 2023-08-01 | — | — | US | disclosed |
| CN-114315678-A | Novel aryl diperoxy acid and preparation method and application thereof | 哈尔滨工业大学（深圳） | 2022-04-12 | — | — | CN | disclosed |
| EP-3939989-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA 4BETA 7 INTEGRIN | Zealand Pharma A/S (DK) | 2022-01-19 | — | — | EP | disclosed |
| US-20210324007-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ZEALAND PHARMA A/S (DK) | 2021-10-21 | — | — | US | disclosed |
| US-11111273-B2 | Cyclic peptides multimers targeting alpha-4-beta-7 integrin | ZEALAND PHARMA A/S (DK) | 2021-09-07 | — | — | US | disclosed |
| US-20200216501-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ZEALAND PHARMA A/S (DK) | 2020-07-09 | — | — | US | disclosed |
| CN-103992248-A | Aromatic side-chain type sulfonated dihalobiphenyl and preparing method thereof | BEIJING INST TECHNOLOGY | 2014-08-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11111273-B2 | Cyclic peptides multimers targeting alpha-4-beta-7 integrin | ITGB7, ITGB4, ITGA4 | KEAP1 4446/4885TTR 1219/4885HSD17B10 4629/4885 |
| US-12077611-B2 | Cyclic peptides multimers targeting α4β7 integrin | ITGB7, ITGB4, ITGA4 | KEAP1 4563/4885TTR 766/4885HSD17B10 4421/4885 |
| US-20200216501-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ITGB7, ITGB4, ITGA4 | KEAP1 4446/4885TTR 1219/4885HSD17B10 4629/4885 |
| US-20230406884-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ITGB7, ITGB4, ITGA4 | KEAP1 4446/4885TTR 1219/4885HSD17B10 4629/4885 |
| US-11713338-B2 | Cyclic peptides multimers targeting α-4-β-7 integrin | ITGB7, ITGB4, ITGA4 | KEAP1 4312/4885TTR 1209/4885HSD17B10 4644/4885 |
| US-20210324007-A1 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA-4-BETA-7 INTEGRIN | ITGB7, ITGB4, ITGA4 | KEAP1 4398/4885TTR 1303/4885HSD17B10 4609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.